Careau V, et al.Curr Biol. 2021 Aug 26:S0960-9822(21)01120-9. doi: 10.1016/j.cub.2021.08.016. Online ahead of print.Curr Biol. 2021.PMID: 34453886.
Item in Clipboard
.
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]".
Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, Álvarez L, Fleitas PE, Ceballos L, Golemba M, Fernández F, de Oliveira DF, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C.. Grotta JC, et al.N Engl J Med. 2021 Sep 9;385(11):971-981. doi: 10.1056/NEJMoa2103879.N Engl J Med. 2021.PMID: 34496173.
.
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderon-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello Coronel ML, Martinez-Gonzalez AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MDC, Villares P, Perez de Oteyza J, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Diaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcami J, Bueno JL, Duarte RF..